Oct 31, 2024 • 6:30 AM EDT Matinas BioPharma Announces the Termination of MAT2203 Partnership Negotiations and Implements Immediate Workforce Reduction
Aug 14, 2024 • 4:05 PM EDT Matinas BioPharma Reports Second Quarter 2024 Financial Results and Provides a Business Update
Aug 7, 2024 • 7:00 AM EDT Matinas BioPharma to Webcast Conference Call to Discuss Second Quarter 2024 Financial Results and Provide a Business Update on August 14, 2024